(GLP-1) Sema is a synthetic peptide analog of human glucagon-like peptide-1 (GLP-1), designed to mimic the effects of this naturally occurring incretin hormone
Sources SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022) primary clinical trial reporting GI side-effect rates by dose for tirzepatide
General evidence for probiotics in gastrointestinal symptom management shows mixed results
The most commonly recommended volume is 2.0 mL, which creates a concentration of 2.5 mg/mL
Clinically-proven Weight Loss Programs, Body Aesthetics, and Wellness Solutions in Laurel, MD Achieve lasting weight loss with personalized programs, advanced body contouring treatments, expert medical supervision, and in-person care in Laurel, Maryland or telehealth support when appropriate
Similarly, TGF- levels were significantly elevated in TAA-treated mice relative to the control values